Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00169767 · ClinicalTrials.gov registry record
Holmium Laser Ablation of the Prostate (HoLAP) Versus KTP Laser Vaporization of the Prostate
A clinical trial, sponsored by Indiana Kidney Stone Institute.
- Terminated
- Registry status
- 18
- Enrollment target
NCT00169767 is a clinical trial that was terminated before completion, run by Indiana Kidney Stone Institute. The registered enrollment target is 18 participants.
The verdict
NCT00169767 was terminated before completion, sponsored by Indiana Kidney Stone Institute.
- TERMINATED
- Registry status
- 18 participants
- Enrollment target
Study Summary
Many options currently exist to relieve the symptoms caused by benign prostatic hyperplasia (BPH). At present, transurethral resection of the prostate (TURP) serves as the surgical standard to which all other operative treatments are compared. Although TURP provides excellent short and long-term results, this procedure has many potential risks and complications. The desire to avoid the potential risks of TURP and still achieve results of comparable durability has led to the development of alternative surgical procedures. One such surgical alternative in the treatment of BPH is holmium laser ablation of the prostate (HoLAP). HoLAP has been compared to TURP in a randomized clinical trial with comparable outcomes in both uroflow rate and symptom score improvements (Mottet, et al 1999). Use of the holmium laser in treating BPH provides specific advantages over TURP. The risk of dilutional hyponatremia is eliminated, as the holmium laser can be used in conjunction with a normal saline irrigant. In addition, the hemostatic properties of the holmium laser results in superior hemostasis, thus minimizing the risk of bleeding. HoLAP has been utilized for prostate glands up to 60 grams in volume, as larger glands become more inefficient to treat using a tissue vaporization technique. Recently, another laser technology has been introduced for the surgical treatment of BPH, the potassium titanyl-phosphate (KTP) laser. This modality can also be used to vaporize obstructive prostate tissue, and has been studied through single arm clinical studies. Short-term results are promising, with significant improvements in voiding symptoms and urine flow rates as well as minimal associated morbidity. However, to date a randomized comparison study between HoLAP and KTP laser vaporization of the prostate has not been reported. A group of investigators with extensive experience with both procedures intends to objectively compare these two procedures in a randomized clinical trial.
Interventions
- OTHER Comparison study between KTP and HoLAP for BPH
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2005-05 |
| Est. Completion | 2008-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00169767
The ClinicalTrials.gov registry entry for NCT00169767 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana Kidney Stone Institute, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Comparison study between KTP and HoLAP for BPH is the first listed.
NCT00169767 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00169767 about?
NCT00169767 is a clinical study titled "Holmium Laser Ablation of the Prostate (HoLAP) Versus KTP Laser Vaporization of the Prostate". Many options currently exist to relieve the symptoms caused by benign prostatic hyperplasia (BPH). At present, transurethral resection of the prostate (TURP) serves as the surgical standard to which all other operative treatments are compared. Although TURP provides excellent short and long-term res...
What is the current status of trial NCT00169767?
This trial is currently terminated. The enrollment target is 18 participants. The study started on 2005-05. Estimated completion is 2008-04.
What interventions are being tested in trial NCT00169767?
The interventions under investigation include: Comparison study between KTP and HoLAP for BPH (OTHER).
Who is sponsoring clinical trial NCT00169767?
This trial is sponsored by Indiana Kidney Stone Institute, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.